Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma

被引:9
|
作者
Li, Ping [1 ,2 ,3 ]
Bian, Xue-yan [1 ,2 ,3 ,4 ]
Chen, Qing [3 ,4 ]
Yao, Xiao-feng [1 ,2 ,3 ]
Wang, Xu-dong [1 ,2 ,3 ]
Zhang, Wen-chao [1 ,2 ,3 ]
Tao, Ying-jie [1 ,2 ,3 ]
Jin, Rui [1 ,2 ,3 ]
Zhang, Lun [1 ,2 ,3 ]
机构
[1] Tianjin Med Univ, Canc Inst & Hosp, Dept Maxillofacial Oncol, Tianjin, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Dept Otorhinolaryngol Oncol, Tianjin, Peoples R China
[3] Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
[4] Tianjin Med Univ, Canc Inst & Hosp, Cardiopulm Funct Lab, Tianjin, Peoples R China
来源
PLOS ONE | 2017年 / 12卷 / 05期
基金
中国国家自然科学基金;
关键词
EXTRACELLULAR-SUPEROXIDE DISMUTASE; ER STRESS INDUCER; CANCER; CALCIUM; STIM1; THAPSIGARGIN; METASTASIS; ACTIVATION; MIGRATION; PLAYS;
D O I
10.1371/journal.pone.0177484
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Calcium signal plays an important role in a variety of cancer cell metabolism, but knowledge on its role in head and neck squamous cell carcinoma (HNSCC) is limited. Store-operated calcium entry (SOCE) is the principal Ca2+ entry mechanism that maintains calcium concentration and produces calcium signal in non-excitable cells. SOCE is triggered by stromal interaction molecule 1 (STIM1), which is located in endoplasmic reticulum (ER) as Ca2+ sensor. Although, many studies demonstrated that STIM1 and SOCE play important functions in the regulation of many cancer progressions, their clinical relevance in HNSCC remains unclear. In this study, STIM1 expression levels notably increased in 89% HNSCC tissues compared with those in adjacent normal tissues. Meanwhile, this overexpression was close associated with tumor size but not with neck lymph node metastasis. Thus, this study mainly focuses on STIM1 function in HNSCC tumor growth. Three HNSCC cell lines, namely, TSCCA (oral cancer cell line) and Hep2 (laryngeal cell line) with high STIM1 expression levels and Tb3.1 (oral cancer cell line) with STIM1 expression level lower than previous two cell lines, were selected for in vitro study. Downregulated STIM1 expression levels in TSCCA and Hep2 arrested cells in G0/G1 stages, promoted cell apoptosis, and inhibited cell proliferation. By contrast, upregulated STIM1 expression in Tb3.1 inhibited cell apoptosis and promoted cell proliferation. Induced by thapsigargin (TG), ER stress was amplified when STIM1 expression was downregulated but was attenuated as STIM1 expression was upregulated. Furthermore, TSCCA cell xenograft models confirmed that STIM1 could promote HNSCC tumor growth in vivo. The present study provides new insight into HNSCC molecular mechanism and potential therapeutic target through targeting SOCE-dependent process. However, whether STIM1 participates in HNSCC metastasis requires further study.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] The influence of ethanol on a squamous cell carcinoma cell line of the head and neck
    Temmel, AFP
    Formanek, M
    Vajs, A
    Knerer, B
    Kornfehl, J
    HEAD AND NECK CANCER - ADVANCES IN BASIC RESEARCH, 1996, 1114 : 35 - 40
  • [22] Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma
    Hoogsteen, IJ
    Marres, HAM
    Wijffels, KIEM
    Rijken, PFJW
    Peters, JPW
    van den Hoogen, FJA
    Oosterwijk, E
    van der Kogel, AJ
    Kaanders, JHAM
    CLINICAL CANCER RESEARCH, 2005, 11 (01) : 97 - 106
  • [23] EXPRESSION OF THE CELL-CELL ADHESION MOLECULE E-CADHERIN IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    BOWIE, GL
    CASLIN, AW
    ROLAND, NJ
    FIELD, JKMA
    JONES, AS
    KINSELLA, AR
    CLINICAL OTOLARYNGOLOGY, 1993, 18 (03): : 196 - 201
  • [24] ECRG4 inhibits growth and invasiveness of squamous cell carcinoma of the head and neck in vitro and in vivo
    Xu, Ting
    Xiao, Dajiang
    Zhang, Xin
    ONCOLOGY LETTERS, 2013, 5 (06) : 1921 - 1926
  • [25] Oncogenic BTK Promotes Growth and Vascularization of Head and Neck Squamous Cell Carcinoma (HNSCC) in Vitro and in Vivo
    Staufenberg, Anna-Rebekka
    Strobel, Hannah
    Lesakova, Kristina
    Azoitei, Ninel
    Sporleder, Johanna
    Ezic, Jasmin
    Kolarova, Julia
    Drees, Robert
    Weissinger, Stephanie E.
    Ushmorov, Alexey
    Doescher, Johannes
    Theodoraki, Marie-Nicole
    Schuler, Patrick
    Laban, Simon
    Ammerpohl, Ole
    Hoffmann, Thomas K.
    Grassili, Emanuela
    Brunner, Cornelia
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 95 - 96
  • [26] Expression of galectins in head and neck squamous cell carcinoma
    Gillenwater, A
    Xu, XC
    ElNaggar, AK
    Clayman, GL
    Lotan, R
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1996, 18 (05): : 422 - 432
  • [27] Nucleostemin expression in squamous cell carcinoma of the head and neck
    Cada, Zdenek
    Boucek, Jan
    Dvorankova, Barbora
    Chovanec, Martin
    Plzak, Jan
    Kodet, Roman
    Betka, Jan
    Pinot, Gian L.
    Gabius, Hans-Joachim
    Smetana, Karel, Jr.
    ANTICANCER RESEARCH, 2007, 27 (5A) : 3279 - 3284
  • [28] Plakophilin1 expression in head and neck squamous cell carcinoma
    Sobolik-Delmaire, Tammy I.
    Katafiasz, Dawn M.
    Ferrell, Anita D.
    Mahoney, My
    Wahl, James K., III
    CANCER RESEARCH, 2006, 66 (08)
  • [29] Ultrasound hyperthermia induces apoptosis in head and neck squamous cell carcinoma: An in vitro study
    Ren, Guoxin
    Jv, Houyu
    Tian, Zhuowei
    Gvetadze, Shalva R.
    Hu, Jingzhou
    Zhao, Mei
    Zhou, Ge
    Zhang, Chenping
    Zhang, Zhiyuan
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2017, 22 (03): : E289 - E296
  • [30] Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo
    Liu, Yong
    Yu, Changyun
    Qiu, Yuanzheng
    Huang, Donghai
    Zhou, Xiaojuan
    Zhang, Xin
    Tian, Yongquan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (02) : 195 - 202